Hemgenix - An Overview
Variety of qualified individuals: CDEC talked about the uncertainty in the quantity of clients with reasonably serious to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific specialists consulted by CADTH indicated that some patients that are categorized as possessing gentle or moderate illness may have a severe bleedi